IRIS UniCatt

Morganti, Alessio Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.539
EU - Europa 9.002
AS - Asia 8.024
SA - Sud America 1.409
Continente sconosciuto - Info sul continente non disponibili 827
AF - Africa 246
OC - Oceania 19
Totale 31.066
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.140
SG - Singapore 3.758
DE - Germania 3.459
CN - Cina 1.843
SE - Svezia 1.474
BR - Brasile 1.157
IT - Italia 859
FR - Francia 740
VN - Vietnam 728
UA - Ucraina 654
GB - Regno Unito 414
IN - India 379
IE - Irlanda 349
FI - Finlandia 278
CA - Canada 246
ID - Indonesia 242
JP - Giappone 208
PL - Polonia 193
BD - Bangladesh 166
TR - Turchia 153
RU - Federazione Russa 152
HK - Hong Kong 141
AR - Argentina 93
BE - Belgio 77
MX - Messico 71
CI - Costa d'Avorio 68
NL - Olanda 66
IQ - Iraq 65
CZ - Repubblica Ceca 57
ZA - Sudafrica 57
ES - Italia 48
EC - Ecuador 39
SA - Arabia Saudita 38
AT - Austria 37
IR - Iran 34
CO - Colombia 33
KR - Corea 28
MA - Marocco 28
PK - Pakistan 28
UZ - Uzbekistan 27
VE - Venezuela 25
EG - Egitto 24
KE - Kenya 22
PH - Filippine 21
CH - Svizzera 20
CL - Cile 19
JO - Giordania 19
LT - Lituania 19
JM - Giamaica 18
AE - Emirati Arabi Uniti 16
AU - Australia 16
NP - Nepal 15
RO - Romania 15
AZ - Azerbaigian 13
MY - Malesia 13
PY - Paraguay 13
EU - Europa 12
TT - Trinidad e Tobago 12
UY - Uruguay 12
AL - Albania 10
IL - Israele 10
TN - Tunisia 10
BG - Bulgaria 9
PE - Perù 9
PT - Portogallo 9
BO - Bolivia 8
DK - Danimarca 8
KG - Kirghizistan 8
OM - Oman 8
PS - Palestinian Territory 8
RS - Serbia 8
SY - Repubblica araba siriana 8
DZ - Algeria 7
ET - Etiopia 7
HN - Honduras 7
KZ - Kazakistan 7
LK - Sri Lanka 7
NI - Nicaragua 7
PA - Panama 7
CR - Costa Rica 6
DO - Repubblica Dominicana 6
GR - Grecia 6
HU - Ungheria 6
SN - Senegal 6
AM - Armenia 5
LA - Repubblica Popolare Democratica del Laos 5
LU - Lussemburgo 5
TH - Thailandia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AO - Angola 4
BH - Bahrain 4
BS - Bahamas 4
HR - Croazia 4
NO - Norvegia 4
SI - Slovenia 4
TW - Taiwan 4
EE - Estonia 3
LB - Libano 3
LV - Lettonia 3
MK - Macedonia 3
Totale 30.207
Salva come PNG Salva come JPEG
Città #
Singapore 2.024
Chandler 1.540
Ashburn 1.088
San Jose 1.045
Beijing 392
Jacksonville 387
Los Angeles 380
Dublin 344
New York 324
San Mateo 310
The Dalles 266
Ho Chi Minh City 239
Nanjing 232
Lauterbourg 228
Jakarta 218
Dearborn 216
Ann Arbor 215
Wilmington 198
Hanoi 196
Milan 193
Nürnberg 183
Tokyo 171
Warsaw 170
Boston 167
Munich 166
Woodbridge 154
Frankfurt am Main 140
Hefei 140
Dallas 135
Bremen 127
Hong Kong 120
Marseille 119
São Paulo 117
Buffalo 112
Lawrence 104
Helsinki 103
Izmir 101
Santa Clara 101
Rome 98
Houston 96
Hyderabad 95
Nanchang 92
Cattolica 89
Toronto 88
Moscow 87
Princeton 85
Fairfield 77
Seattle 76
Brussels 75
Redwood City 72
Abidjan 68
Chicago 64
Leawood 61
Boardman 53
St Louis 50
Council Bluffs 48
London 48
Paris 48
Shanghai 47
Orem 44
Zhengzhou 44
North York 43
Guangzhou 42
Brooklyn 39
University Park 39
Kunming 38
Stockholm 38
Augusta 37
Shenyang 37
Düsseldorf 36
Hebei 36
Atlanta 35
Jiaxing 35
Amsterdam 34
Tianjin 34
Montreal 33
Fremont 32
Kent 32
Da Nang 31
Changsha 30
Lancaster 30
Nuremberg 30
Turku 30
Denver 29
Cambridge 28
Charlotte 28
Detroit 28
Johannesburg 28
Phoenixville 28
Rio de Janeiro 28
Mumbai 27
Mountain View 26
Norwalk 26
Pune 26
Lappeenranta 25
Washington 25
Belo Horizonte 24
Phoenix 24
Seoul 24
Auburn Hills 23
Totale 15.288
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 866
Combined-modality therapy in locally advanced primary rectal cancer 356
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 319
A National project for in vivo dosimetry procedures in radiotherapy: First results 310
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 302
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 237
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 233
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 232
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 230
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 230
A National project for in vivo dosimetry procedures in radiotherapy: First results 227
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 222
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 219
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 217
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 212
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 202
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 197
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 196
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 196
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 195
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 194
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 191
In Vivo Portal Dosimetry by an Ionization Chamber 190
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 190
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 189
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 188
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 187
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 187
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 186
Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: Is there a place for critical swallowing structures dose sparing? 186
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 185
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 185
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 184
Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review 181
Electrochemotherapy with intravenous bleomycin for heavily pre-treated vulvar cancer patients 180
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 177
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 177
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 176
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 176
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 175
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 175
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 174
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 174
Advanced head and neck cancer in older adults: Results of a short course accelerated radiotherapy trial 173
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 172
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 171
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 171
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 170
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 170
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 166
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 166
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 166
La formazione iniziale e continua degli insegnanti. Relazioni, comunicazione, metodi. Sessioni parallele 165
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 165
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 165
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 164
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 164
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 162
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 162
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 158
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 158
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 158
An in-vivo dosimetry procedure for Elekta step and shoot IMRT 158
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 158
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 157
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 156
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 156
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 156
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 156
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 156
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 154
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer 154
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 153
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 152
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 152
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 152
Real time transit dosimetry for the breath-hold radiotherapy technique experience 149
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 149
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 147
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 146
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 144
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 143
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 143
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 142
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 142
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 142
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 141
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 141
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7) 141
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 140
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 140
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 140
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 139
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 138
Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation 138
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 137
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 137
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 137
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 135
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 133
Totale 18.305
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.178
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.178
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.822 188 130 32 108 116 69 28 257 73 125 332 364
2022/20234.181 569 590 312 678 273 475 230 342 464 37 160 51
2023/20241.806 66 532 83 149 44 231 103 137 18 49 235 159
2024/20254.019 107 98 253 141 430 95 83 186 658 435 812 721
2025/202610.866 1.551 327 561 957 1.835 562 1.787 633 800 767 355 731
2026/2027541 541 0 0 0 0 0 0 0 0 0 0 0
Totale 31.066